122 related articles for article (PubMed ID: 16970914)
1. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
2. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
3. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
[TBL] [Abstract][Full Text] [Related]
4. Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36.
Wang Y; Van Oort MM; Yao M; Van der Horst DJ; Rodenburg KW
Biol Trace Elem Res; 2011 Sep; 142(3):735-47. PubMed ID: 20721637
[TBL] [Abstract][Full Text] [Related]
5. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism.
Chen G; Liu P; Pattar GR; Tackett L; Bhonagiri P; Strawbridge AB; Elmendorf JS
Mol Endocrinol; 2006 Apr; 20(4):857-70. PubMed ID: 16339278
[TBL] [Abstract][Full Text] [Related]
6. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
Wang YQ; Yao MH
J Nutr Biochem; 2009 Dec; 20(12):982-91. PubMed ID: 19195868
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
8. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
[TBL] [Abstract][Full Text] [Related]
9. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
10. Insulin-stimulated fusion of GLUT4 vesicles to plasma membrane is dependent on wortmannin-sensitive insulin signaling pathway in 3T3-L1 adipocytes.
Kawaguchi T; Tamori Y; Yoshikawa M; Kanda H; Kasuga M
Kobe J Med Sci; 2008 Oct; 54(4):E209-16. PubMed ID: 19258741
[TBL] [Abstract][Full Text] [Related]
11. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
Basuki W; Hiromura M; Sakurai H
J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
Whiteman EL; Chen JJ; Birnbaum MJ
Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
[TBL] [Abstract][Full Text] [Related]
13. A new oxovanadium complex enhances renal function by improving insulin signaling pathway in diabetic mice.
Liu Y; Chen DD; Xing YH; Ge N; Zhang Y; Liu J; Zou W
J Diabetes Complications; 2014; 28(3):265-72. PubMed ID: 24636761
[TBL] [Abstract][Full Text] [Related]
14. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.
Worrall DS; Olefsky JM
Mol Endocrinol; 2002 Feb; 16(2):378-89. PubMed ID: 11818508
[TBL] [Abstract][Full Text] [Related]
15. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
[TBL] [Abstract][Full Text] [Related]
18. ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signaling.
Li X; Wang F; Xu M; Howles P; Tso P
Sci Rep; 2017 Jan; 7():41289. PubMed ID: 28117404
[TBL] [Abstract][Full Text] [Related]
19. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.
Wada T; Hori S; Sugiyama M; Fujisawa E; Nakano T; Tsuneki H; Nagira K; Saito S; Sasaoka T
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E881-8. PubMed ID: 20071559
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
